About 1 Trademarks found for “NAXIO*”

Pharmaceutical products for the treatment of cancer or infectious diseases, namely, genetically engineered hematopoietic cells for the treatment of cancer or infectious diseases; pharmaceutical preparations for cell therapy, namely, genetically engineered hematopoietic cells for the treatment of cancer or infectious diseases; biological preparations for cancer therapies and anti-infective therapies, namely, chimeric antigen receptors (CAR) and therapeutic preparations thereof, namely, viral vectors and plasmid vectors expressing CAR genes; therapeutic antibodies for use as immunotherapeutic agents for the treatment of cancer and infectious diseases; therapeutic T-cell receptors for use as immunotherapeutic agents for the treatment of cancer and infectious diseases; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors and plasmid vectors.

Industrial and scientific analysis in the field of pharmaceuticals and biotechnology, namely, in the field of genetically engineered hematopoietic cells, cell therapies, chimeric antigen receptors (CAR), therapeutic antibodies, therapeutic T-cell receptors, viral vectors and plasmid vectors; scientific research services in the field of pharmaceuticals and biotechnology, namely, genetically modifying human or animal cells to enable cells to be used for therapeutic purposes; scientific research in the development of cancer therapies or anti-infective therapies, namely, in the development of genetically engineered hematopoietic cells, cell therapies, chimeric antigen receptors (CAR), therapeutic antibodies, therapeutic T-cell receptors and viral vectors and plasmid vectors.